XML 51 R41.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 15 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2021
Jul. 08, 2021
Jun. 30, 2021
Feb. 06, 2014
Option Indexed to Issuer's Equity [Line Items]                
Preferred Stock, Shares Authorized 10,000,000   10,000,000       10,000,000  
Preferred Stock, Par or Stated Value Per Share $ 0.0001   $ 0.0001       $ 0.0001  
Common stock, shares authorized 100,000,000   100,000,000       100,000,000  
Common stock, par value $ 0.0001   $ 0.0001       $ 0.0001  
Common stock, shares issued 52,798,267   52,798,267       52,219,661  
Common stock, shares outstanding 52,798,267   52,798,267       52,219,661  
Obligation to purchase           $ 20,000,000    
Purchase of shares           200,000    
Exceed amount           $ 1,000,000    
Purchase agreement description     limited to 12,016,457 shares of Common Stock, representing 19.99%          
Number of shares issued 60,000   337,340          
Number of shares purchase $ 451,700   $ 3,500,039          
Common stock reserved for issuance 17,414   17,414       17,414  
Stock based compensation $ 577,676 $ 499,428 $ 5,348,943 $ 1,184,975        
Unrecognized compensation cost $ 7,184,117   $ 7,184,117          
Number of shares issued options to purchase 60,000   60,000          
Share-Based Payment Arrangement, Option [Member]                
Option Indexed to Issuer's Equity [Line Items]                
Options Granted     4,729,508          
Options Exercisable 1,283,729   1,283,729          
Employee Stock Option One [Member]                
Option Indexed to Issuer's Equity [Line Items]                
Intrinsic value of stock option $ 1,153,019   $ 1,153,019          
2014 Equity Incentive Plan [Member]                
Option Indexed to Issuer's Equity [Line Items]                
Common stock reserved for issuance               1,206,000
DanDrit Denmark [Member]                
Option Indexed to Issuer's Equity [Line Items]                
Common stock, shares outstanding 167,639   167,639          
Agreement and Plan of Merger (the "Acquisition Agreement") [Member]                
Option Indexed to Issuer's Equity [Line Items]                
Options Granted 65,000   65,000          
Options vesting period   1 year   1 year        
Agreement and Plan of Merger (the "Acquisition Agreement") [Member] | N 2019 Equity Incentive Plan [Member]                
Option Indexed to Issuer's Equity [Line Items]                
Options Granted 11,900 9,201 3,142,100   9,201      
Options vesting period 3 years 3 years            
Board Of Directors And Scientific Advisory Members [Member]                
Option Indexed to Issuer's Equity [Line Items]                
Options Granted 23,314 52,500 86,776 140,131        
Agreement and Plan of Merger (the "Acquisition Agreement") [Member] | Enochian Biopharma Inc. and Weird Science LLC [Member]                
Option Indexed to Issuer's Equity [Line Items]                
Common shares contingently issuable 1,250,000   1,250,000          
Common Stock [Member]                
Option Indexed to Issuer's Equity [Line Items]                
Number of shares issued 165,000 1,032,732 578,606 1,298,543        
Black Scholes [Member]                
Option Indexed to Issuer's Equity [Line Items]                
Number of option issued     21,979          
Vesting for services     $ 24,500          
Restricted Stock [Member]                
Option Indexed to Issuer's Equity [Line Items]                
Stock based compensation $ 228 $ 147,000 $ 258,559 $ 147,000        
Lincoln Park [Member]                
Option Indexed to Issuer's Equity [Line Items]                
Issued shares 139,567   139,567          
DanDrit Denmark [Member]                
Option Indexed to Issuer's Equity [Line Items]                
Purchase of shares           125,000